These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fresh data on new anti-HIV drugs presented in Durban. Leibovich M Posit Living; 2000 Aug; 9(7):16-7. PubMed ID: 12492026 [No Abstract] [Full Text] [Related]
6. New package inserts for efavirenz and T-20. AIDS Clin Care; 2007 Mar; 19(3):24. PubMed ID: 17595717 [No Abstract] [Full Text] [Related]
9. FUZEON (enfuvirtide, T-20). Breaking barriers or breaking the bank? Sharp M; Camp R GMHC Treat Issues; 2003 Mar; 17(3):7-8. PubMed ID: 12728858 [No Abstract] [Full Text] [Related]
10. T-20 small program, CD4 < 50, will enroll November 27 at 3:00 P.M. James JS AIDS Treat News; 2001 Oct; (373):3. PubMed ID: 11768880 [No Abstract] [Full Text] [Related]
18. Fusion inhibitor approved. AIDS Patient Care STDS; 2003 May; 17(5):253. PubMed ID: 12816619 [No Abstract] [Full Text] [Related]
19. US FDA approves new class of HIV therapeutics. Robertson D Nat Biotechnol; 2003 May; 21(5):470-1. PubMed ID: 12721558 [No Abstract] [Full Text] [Related]
20. [Fusion inhibitors. One year therapy with T-20--initial evaluation]. Goebel FD MMW Fortschr Med; 2004 Apr; 146 Spec No 1():42-3. PubMed ID: 15373046 [No Abstract] [Full Text] [Related] [Next] [New Search]